FIELD: medicine.
SUBSTANCE: digestive agent represents a complex enzyme preparation containing protease produced by Bacillus licheniformis bacteria, alpha amylase produced by Bacillus amyloliquefaciens bacteria and lipase produced by Yarrowia lipolytica yeast. The ration (activity unit) is specified to be equal to 0.055:0.85:1 respectively.
EFFECT: extended range of digestive agents of high pharmacological activity of microbial enzymes.
6 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL AGENT "GASTROPEK" FOR IMPROVING DIGESTION PROCESS AND METHOD FOR ITS USING | 2004 |
|
RU2276974C2 |
| Bacillus amyloliquefaciens STRAIN - ALPHA AMYLASE PRODUCER FROM Bacillus amyloliquefaciens | 2010 |
|
RU2455352C1 |
| ENZYMES FOR PHARMACEUTICAL APPLICATION | 2005 |
|
RU2389504C2 |
| DRUG FOR TREATING DIABETES CASES | 2000 |
|
RU2268065C2 |
| USE OF ALPHA-1,4/1,6-GLYCOSIDE HYDROLASES ACTIVE AT LOW pH VALUE AS FEED ADDITIVE FOR RUMINANTS FOR IMPROVEMENT OF STARCH DIGESTION | 2021 |
|
RU2791882C2 |
| USING ENZYMES PREPARED FROM INFUSORIA AS DIGESTION-PROMOTING MEDICINAL AGENTS | 2001 |
|
RU2299074C2 |
| PROTEASES FOR PHARMACEUTICAL APPLICATION | 2006 |
|
RU2420578C2 |
| USE OF ALPHA-1,4/1,6-GLYCOSIDE HYDROLASE ACTIVE AT LOW pH AS FEED ADDITIVE FOR RUMINANTS TO IMPROVE STARCH DIGESTION | 2017 |
|
RU2763378C2 |
| HIGH POTENCY PANCREATIN PHARMACEUTICAL COMPOSITIONS | 2014 |
|
RU2686460C2 |
| METHOD FOR PRODUCING IMMOBILIZED BACTERIAL CELL PREPARATION WITH AMYLASE AND LIPASE ACTIVITY | 2022 |
|
RU2804526C1 |
